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Abstract
The current pandemic influenza A H1N1 2009 (pH1N1) was first recognized in humans with acute respiratory dis-
eases in April 2009 in Mexico, in swine in Canada in June, 2009 with respiratory disease, and in turkeys in Chile in
June 2009 with a severe drop in egg production. Several experimental studies attempted to reproduce the disease
in turkeys, but failed to produce respiratory infection in turkeys using standard inoculation routes. We demon-
strated that pH1N1 virus can infect the reproductive tract of turkey hens after experimental intrauterine inoculation,
causing decreased egg production. This route of exposure is realistic in modern turkey production because turkey
hens are handled once a week for intrauterine insemination in order to produce fertile eggs. This understanding of
virus exposure provides an improved understanding of the pathogenesis of the disease and can improve poultry
husbandry to prevent disease outbreaks.
Findings
Because of the known susceptibility of turkeys to type A
influenza viruses and the history of infection with triple
reassortant viruses [1-6], when the pandemic influenza
A H1N1 2009 (pH1N1) emerged, the possibility of tur-
keys becoming infected with the novel virus was investi-
gated. However, experimental challenge with pH1N1
virus by the respiratory route showed that both turkey
poults and adult turkey hens were resistant to infection
[7-9], but infection was produced in young turkeys by
the novel intracloacal route of inoculation (J. Pasick,
personal communication). In August 2009, pH1N1 virus
was detected in two turkey breeder farms in Chile pre-
senting drops in egg production [10]. Epidemiological
investigations on the possible source of infection identi-
fied workers with respiratory problems, and hen insemi-
nation as a risk factor for virus transmission to the
birds. A second and third outbreak in turkey hens
occurred in Canada, in September 2009, and in the
USA, in November 2009, with a marked drop in egg
production as the primary clinical sign of disease
[11,12]. These three outbreaks of pH1N1 influenza in
turkeys raised the question of how the turkey hens
became infected when experimental evidence suggested
that turkeys were refractory to respiratory infection.
In our previous study, 73-week-old turkey hens and 3-
week-old turkey poults were intranasally inoculated with
A/Mexico/4108/09 (H1N1) [8]. None of the turkeys
developed clinical signs or died, no virus was detected
in tissues, and all turkeys were negative for antibodies to
the virus, indicating that they did not become infected.
In another study, 21- and 70-day-old meat turkeys were
oro-nasally inoculated with A/Italy/2810/2009 (H1N1)
influenza virus. Virus was not recovered by molecular or
conventional methods from blood, tracheal and cloacal
swabs, lungs, intestine or muscle tissue, and only some
birds seroconverted [9]. In a third study, inoculation of
3-week-old turkeys with A/CA/07/09 (H1N1) through
the intranasal and intraocular route also failed to initiate
infection [7].
In order to understand how the pH1N1 virus poten-
tially had infected turkey breeders, we conducted a
study in which we inoculated 53-week-old laying turkey
hens with 10
5.3 50% cell culture infective doses of A/
Chile/3536/2009 (H1N1) virus by three different routes.
Eight hens were inoculated intranasally (IN), four hens
were inoculated intracloacally (IC), and four hens were
inoculated through the intrauterine (IU) route. Orophar-
yngeal and cloacal swabs were taken from all hens at
days 2, 4, 7, 10, and 14 days post-inoculation (dpi), and
lung, spleen, heart, kidney and oviduct were taken from
one hen per group at 3 and 7 dpi for virus detection by
quantitative real-time reverse transcriptase polymerase
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enza virus matrix gene with the described modified
reverse primer 3’-cagagactggaaagtgtctttgca-5’ [8,13]. Tis-
sues were also taken for histology and viral antigen
detection by immunohistochemistry (IHC). For IHC,
mouse monoclonal antibody P13C11, specific for influ-
enza A nucleoprotein, was used. Sections were stained
as previously described [14]. Serum was collected from
the remaining turkeys at the end of the 14-day study for
antibody testing by hemagglutination inhibition (HI).
None of the turkeys inoculated IN with the pH1N1
virus developed clinical signs. Turkeys inoculated IC or
IU presented with mild diarrhea from 1 to 4 dpi. Tur-
keys inoculated by the IU route stopped laying eggs at 5
dpi, while turkeys IC inoculated laid eggs daily through
9 dpi. Turkeys IN-inoculated continued laying eggs until
the end of the study. Turkeys inoculated IN or IC,
necropsied at 3 and 7 dpi, presented no gross lesions
and had active oviducts. The oviducts of the turkeys
inoculated IU were congested or undergoing involution
at 3 and 7 dpi, respectively. All IN-inoculated turkeys
were negative for antibodies to the virus on 14 dpi. One
of two IC-inoculated turkeys had a hemagglutination
inhibition (HI) geometric mean antibody titer of 256,
and both hens inoculated through the IU route had high
HI titers (4096 and 8192) at 14 dpi. The two hens
inoculated either IC or IU and necropsied at 7 dpi also
seroconverted (64 and 256 HI titers, respectively). Virus
Table 1 Results of qRRT-PCR testing for pH1N1 virus in oropharyngeal and cloacal swabs of experimental turkey hens
inoculated intranasally, intracloacally, or intrauterine with A/Chile/3536/2009 (H1N1) virus.
Groups Sampling day (days post inoculation) for swabs
24 7 1 0 1 4
OP
a C
b OP C OP C OP C OP C
IN
c 0/8
d 0/8 0/7 0/7 0/7 0/7 0/6 0/6 0/6 0/6
IC
e 0/4 1/4(10
4.7) 0/4 0/4 0/3 0/3 0/2 0/2 0/2 0/2
IU
f 1/4 (10
4.7)
g 1/4(10
6.7) 3/3(10
4.7) 3/3(10
5.8) 0/3 3/3(10
5.7) 0/2 1/2(10
5.1) 1/2(10
4.8) 0/2
a OP, oropharyngeal.
b C, cloacal.
c IN, intranasal.
d number of virus positive/total sampled.
e IC, intracloacal.
f IU, intrauterine.
g average titer of RNA positive
samples. Previous studies have shown correlation between qRRT-PCR results and infectious titer of influenza A virus for oropharyngeal and cloacal swabs [15]. We
report our qRRT-PCR data in relative equivalent units (REU) based on a standard curve for A/Chile/3536/2009 (H1N1) in mean chicken embryo infectious doses
(EID50)
Figure 1 Photomicrographs of immunohistochemically strained reproductive tracts of turkey breeder hens IU-inoculated with pH1N1
virus. (A to C) Oviducts with influenza viral antigen in luminal lining epithelium, (D) Ovary with influenza viral antigen in surface germinal
epithelium.
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I U - i n o c u l a t e dt u r k e y sf r o m2t o1 4d p i ,a n da t4d p i
from the cloacal swab of one IC-inoculated turkey
(Table 1). Virus was detected in the oviduct of the tur-
keys IC- or IU-inoculated, and virus antigen was visua-
lized by immunohistochemical staining in the surface
germinal epithelium of the ovary and luminal epithelium
lining the oviduct (Figure 1). No lesions or viral staining
was present in any of the other tissues examined. No
virus was detected in swabs or tissues from IN-inocu-
lated turkeys.
In this study, and consistent with previous studies,
turkeys IN-inoculated with the pH1N1 influenza virus
did not become infected with the virus, although the
respiratory route is considered the natural route of
exposure for influenza A viruses in many animal species.
However, IC or IU-inoculation with the virus resulted in
pH1N1 virus infection. Such routes of exposure are rea-
listic in modern turkey production because turkey hens
are handled once a week for insemination, which depos-
its semen into the uterus, in order to produce fertile
eggs, because modern tom turkeys are physically unable
to efficiently breed naturally because of their large breast
muscles. During this process, workers handle individual
hens, manually everting the cloaca to locate the vagina
for insertion of the insemination straw. Because of the
close contact with infected humans, this routine insemi-
nation activity provided opportunity for initiating the
infection process by either large droplet exposure during
human sneezing activities or direct inoculation from
infectious fomites on contaminated hands, and bird-to-
bird transmission through mechanical fomite inocula-
tion to the cloaca or reproductive tract by the insemina-
tors. This is the first study to show infection by
intrauterine exposure to influenza A virus in turkeys
and such transmission is consistent with the proposed
risk of infected insemination crews in cases of pH1N1
in Chilean turkey hens [10]. However, replication and
shedding from the respiratory tract following IU-inocu-
lation is perplexing considering IN-inoculation failed to
produce infection. Possibly, the IU-inoculation and
infection resulted in changes in the virus that allowed
subsequent respiratory infection. Future studies will
examine such viruses recovered from respiratory tract
for changes in viral tissue tropism.
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